Autophagy regulation by microRNAs in chemotherapy resistance (Review)

Oncol Rep. 2020 Sep;44(3):791-797. doi: 10.3892/or.2020.7655. Epub 2020 Jun 22.

Abstract

Chemotherapy, as an adjuvant therapy, utilizes drugs to treat cancer, and resistance to therapeutic drugs limits the efficacy of chemotherapy treatments. Several mechanisms have been proposed to improve the effect of tumor chemotherapy in order to overcome drug resistance. Among these, autophagy mediated by microRNAs (miRNAs) is one of the primary mechanisms. A large number of molecules targeted by miRNAs are involved in each step of the autophagic pathway. Recent advancement in chemotherapy research has revealed that miRNAs involved in the autophagy process target some of these molecules, thereby influencing the therapeutic effect of chemotherapy drugs. Thus, miRNAs appear to be potential tools or targets with which to suppress tumor growth and should be studied in further details for their clinical application against drug resistance.

Keywords: cancer; autophagy; miRNA; chemotherapy resistance.

Publication types

  • Review

MeSH terms

  • Animals
  • Autophagy / drug effects
  • Autophagy / genetics
  • Chemotherapy, Adjuvant
  • Drug Resistance, Neoplasm
  • Humans
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Molecular Targeted Therapy
  • Neoplasms / drug therapy*
  • Neoplasms / genetics*
  • Neoplasms / metabolism
  • Neoplasms / pathology

Substances

  • MicroRNAs